12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. GeneDx Hldgs (NASDAQ:WGS) shar
BenzingaApr 30 08:06 ET
Express News | Virios Therapeutics Shares Are Trading Higher After the Company Announced the Publication of an International Patent Titled "Valacyclovir and Celecoxib for the Treatment of Alzheimer's and COVID-19"
Moomoo 24/7Apr 1 11:21 ET
Virios Therapeutics Announces Publication Of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID
- New patent would extend coverage and expand potential value of Virios' antiviral pipeline globally –- Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactiv
BenzingaMar 26 09:17 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersIMAC Hldgs (NASDAQ:BACK) shares moved upwards by 91.5% to $2.47 during Friday's regular session. The market value of their outstanding shares is at $2.8 million. Virios Therapeutics (NASDAQ:VIR
BenzingaMar 22 13:31 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersYield10 Bioscience (NASDAQ:YTEN) stock increased by 133.7% to $0.57 during Thursday's pre-market session. The market value of their outstanding shares is at $6.8 million. Immunovant (NASDAQ:IMV
BenzingaMar 21 09:05 ET
Virios Therapeutics: A Hold Rating With a New Price Target Amidst Clinical and Financial Challenges
TipRanksMar 6 06:38 ET
Virios Therapeutics Reports Q4 Results
Seeking AlphaMar 1 10:49 ET
Express News | Virios Therapeutics Q4 2023 GAAP EPS $(0.06) Beats $(0.09) Estimate
Moomoo 24/7Feb 29 09:17 ET
Virios Therapeutics: Discussions Ongoing With Potential Partners to Fund Advancement of IMC-1 Into Phase 3 Development for FM >VIRI
Virios Therapeutics: Discussions Ongoing With Potential Partners to Fund Advancement of IMC-1 Into Phase 3 Development for FM >VIRI
Dow JonesFeb 29 09:16 ET
Virios Therapeutics 4Q Loss/Shr 6c >VIRI
Virios Therapeutics 4Q Loss/Shr 6c >VIRI
Dow JonesFeb 29 09:15 ET
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress And Key Upcoming Milestones; All Of Virios' Employees Have Agreed To A 10% Salary Compensation Reduction In Exchange For Future Vesting Stock Options
Virios Therapeutics, Inc. (NASDAQ:VIRI) (the "Company"), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibr
BenzingaFeb 28 09:21 ET
Virios Therapeutics Enacts Salary Cuts and Grants Stock Options
TipRanksFeb 27 16:35 ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersSeaStar Medical Holding (NASDAQ:ICU) shares rose 27.9% to $1.1 during Monday's pre-market session. The company's market cap stands at $71.6 million. Aesthetic Medical Intl (NASDAQ:AIH) shares i
BenzingaFeb 12 08:05 ET
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.36%
InvestingJan 22 16:30 ET
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSagimet Biosciences (NASDAQ:SGMT) stock rose 103.5% to $13.88 during Monday's regular session. The company's market cap stands at $317.8 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved up
BenzingaJan 22 12:31 ET
Crude Oil Surges Over 2%; US Leading Economic Index Falls In December
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday. The Dow traded up 0.41% to 38,018.23 while the NASDAQ rose 0.30% to 15,356.67. The S&P 5
BenzingaJan 22 12:18 ET
US Stocks Higher; Nasdaq Jumps 100 Points
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose 0
BenzingaJan 22 10:15 ET
Express News | Virios Therapeutics To Advance Development Of IMC-2 As Treatment For Symptoms Associated With Long-COVID
Moomoo 24/7Jan 22 09:03 ET
Express News | Virios Said In Shareholder Letter, We Are Exploring Options To Advance The IMC-2 LC Investigational New Drug Application And Its Proposed Phase 2 Research Program
Moomoo 24/7Jan 3 07:11 ET
Virios Therapeutics Reports Receipt Of FDA's Feedback On Requirements For Advancing IMC-2
RTTNewsJan 2 07:40 ET
No Data
No Data